Research And Markets Research And Markets
0 CHECKOUT

Acute Ischemic Stroke - Pipeline Review, H2 2015

  • ID: 3384513
  • July 2015
  • 110 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • AB Science SA
  • AstraZeneca Plc
  • Biogen, Inc.
  • DiaMedica Inc.
  • Digna Biotech, S.L.
  • D-Pharm Ltd.
  • MORE

‘Acute Ischemic Stroke - Pipeline Review, H2 2015’, provides an overview of the Acute Ischemic Stroke’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Acute Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Ischemic Stroke and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Science SA
  • AstraZeneca Plc
  • Biogen, Inc.
  • DiaMedica Inc.
  • Digna Biotech, S.L.
  • D-Pharm Ltd.
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Acute Ischemic Stroke Overview

Therapeutics Development

Pipeline Products for Acute Ischemic Stroke - Overview

Acute Ischemic Stroke - Therapeutics under Development by Companies

Acute Ischemic Stroke - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Acute Ischemic Stroke - Products under Development by Companies

Acute Ischemic Stroke - Companies Involved in Therapeutics Development

AB Science SA

AstraZeneca Plc

Biogen, Inc.

D-Pharm Ltd.

Daiichi Sankyo Company, Limited

DiaMedica Inc.

Digna Biotech, S.L.

Glucox Biotech AB

Grifols, S.A.

Lumosa Therapeutics Co., Ltd.

Mitsubishi Tanabe Pharma Corporation

Pharmicell Co., Ltd.

PhytoHealth Corporation

Remedy Pharmaceuticals, Inc.

Simcere Pharmaceutical Group

Stemedica Cell Technologies, Inc.

ZZ Biotech, LLC

Acute Ischemic Stroke - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

3K3A-APC - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Cerecellgram-Stroke - Drug Profile

Product Description

Mechanism of Action

R&D Progress

DB-017 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

DM-199 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

DS-1040 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

glyburide - Drug Profile

Product Description

Mechanism of Action

R&D Progress

HBN-1 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Human Plasmin - Drug Profile

Product Description

Mechanism of Action

R&D Progress

LT-3001 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

masitinib - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Mesenchymal Stem Cells - Drug Profile

Product Description

Mechanism of Action

R&D Progress

MP-124 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

natalizumab - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke - Drug Profile

Product Description

Mechanism of Action

R&D Progress

PHN-014 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Recombinant Plasmin - Drug Profile

Product Description

Mechanism of Action

R&D Progress

SIM-071201 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecule-1 to Inhibit NOX-4 for Acute Ischemic Stroke - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Small Molecule-2 to Inhibit NOX-4 for Acute Ischemic Stroke - Drug Profile

Product Description

Mechanism of Action

R&D Progress

THR-18 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

ticagrelor - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TS-01 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Acute Ischemic Stroke - Recent Pipeline Updates

Acute Ischemic Stroke - Dormant Projects

Acute Ischemic Stroke - Discontinued Products

Acute Ischemic Stroke - Product Development Milestones

Featured News & Press Releases

Jun 01, 2015: Thrombolytic Science to Collaborate With National Institutes of Health to Test a Novel Thrombolytic Regimen for the Treatment of Acute Ischemic Stroke in Phase IIa Clinical Trial

Mar 19, 2015: DiaMedica to Present at the 12th Annual BIO Asia International Conference

Dec 18, 2014: D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

Nov 04, 2014: D-Pharm Reports First Results From its Phase 2 Clinical Study of THR-18 In Acute Stroke Patients Treated with tPA

Aug 19, 2014: US Department of Justice Closes Investigation into PLATO Clinical Trial for BRILINTA

Jun 02, 2014: D-Pharm Reports Completion of the Second Dose Tier in its Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated with the Thrombolytic Drug tPA

Apr 22, 2014: ZZ Biotech Announces Phase 2 Trial with 3K3A-APC in Stroke; Funds Will Be Provided by NIH and Broadview Ventures

Mar 04, 2014: D-Pharm reports the successful interim analysis of its Phase 2 clinical study of THR-18 in acute stroke patients

Jan 21, 2014: D-Pharm completes recruitment of patients into the first dosage tier of its Phase 2 study with THR-18 in acute stroke patients treated with tPA

Jan 08, 2014: D-Pharm receives grant to support the development of its Phase 2 product, THR-18

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Acute Ischemic Stroke, H2 2015

Number of Products under Development by Companies, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Acute Ischemic Stroke - Pipeline by AB Science SA, H2 2015

Acute Ischemic Stroke - Pipeline by AstraZeneca Plc, H2 2015

Acute Ischemic Stroke - Pipeline by Biogen, Inc., H2 2015

Acute Ischemic Stroke - Pipeline by D-Pharm Ltd., H2 2015

Acute Ischemic Stroke - Pipeline by Daiichi Sankyo Company, Limited, H2 2015

Acute Ischemic Stroke - Pipeline by DiaMedica Inc., H2 2015

Acute Ischemic Stroke - Pipeline by Digna Biotech, S.L., H2 2015

Acute Ischemic Stroke - Pipeline by Glucox Biotech AB, H2 2015

Acute Ischemic Stroke - Pipeline by Grifols, S.A., H2 2015

Acute Ischemic Stroke - Pipeline by Lumosa Therapeutics Co., Ltd., H2 2015

Acute Ischemic Stroke - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2015

Acute Ischemic Stroke - Pipeline by Pharmicell Co., Ltd., H2 2015

Acute Ischemic Stroke - Pipeline by PhytoHealth Corporation, H2 2015

Acute Ischemic Stroke - Pipeline by Remedy Pharmaceuticals, Inc., H2 2015

Acute Ischemic Stroke - Pipeline by Simcere Pharmaceutical Group, H2 2015

Acute Ischemic Stroke - Pipeline by Stemedica Cell Technologies, Inc., H2 2015

Acute Ischemic Stroke - Pipeline by ZZ Biotech, LLC, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Stage and Target, H1 2015

Number of Products by Stage and Mechanism of Action, H1 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Acute Ischemic Stroke Therapeutics - Recent Pipeline Updates, H2 2015

Acute Ischemic Stroke - Dormant Projects, H2 2015

Acute Ischemic Stroke - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Acute Ischemic Stroke, H2 2015

Number of Products under Development by Companies, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Routes of Administration, H2 2015

Number of Products by Stage and Routes of Administration, H2 2015

Number of Products by Molecule Types, H2 2015

Number of Products by Stage and Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

AB Science SA
AstraZeneca Plc
Biogen, Inc.
D-Pharm Ltd.
Daiichi Sankyo Company, Limited
DiaMedica Inc.
Digna Biotech, S.L.
Glucox Biotech AB
Grifols, S.A.
Lumosa Therapeutics Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Pharmicell Co., Ltd.
PhytoHealth Corporation
Remedy Pharmaceuticals, Inc.
Simcere Pharmaceutical Group
Stemedica Cell Technologies, Inc.
ZZ Biotech, LLC

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db